Standardizing assessment of adverse effects in rheumatology clinical trials. Status of OMERACT Toxicity Working Group March 2000: towards a common understanding of comparative toxicity/safety profiles for antirheumatic therapies.
J Rheumatol. 2001 May;28(5):1163-9.
J Rheumatol. 2001.
PMID: 11361207
Review.